Delivery Order SPE2DB22D6029-SPE2DB25FLTZJ

Award Date 2/5/25
Potential Completion Date 2/27/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of PROMACTA 50 MG TABLET UU 30S. The contract has a ceiling value of $14,985.78 and runs through January 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 75 mg tablets. The contract has a ceiling value of $10,852.00 and was awarded on July 17, 2024, with an ultimate completion date of August 7, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of March 12, 2025 and is a firm fixed-price delivery order. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROMACTA 12.5 MG TABLET, a medication, with a ceiling value of $12,412.17 and a period of performance through January 3, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 25 MG TABLET medication. The contract has a ceiling value of $3,997.21 and a period of performance through August 5, 2024. The award was made on July 15, 2024, and there was no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 25 MG TABLET in 30-count units. The contract is a Firm Fixed Price (FFP) arrangement with a ceiling value of $3,997.21 and a period of performance through October 1, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a leading pharmaceutical distributor. The $7,242.58 firm-fixed-price contract is for the supply of PROMACTA 50 MG TABLET, a specialty medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds several key Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, enabling the efficient...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,242.58 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of PROMACTA 50 MG TABLET (National Drug Code 4565046823) and has a completion date of July 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. The award is not associated with a set-aside program and has a ceiling value of $23,983.26. The contract is a Firm Fixed Price delivery order with an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $7,242.58 for the supply of PROMACTA 50 MG TABLET UU 30S. This contract has a firm fixed price and an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTZJ
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 75 MG TABLET UU 30S. The contract has a ceiling value of $20,056.16 and is set to expire on February 27, 2025. It is a Firm Fixed Price contract, with no set-aside designation.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/7/25, 10:08 AM